Fonar Corp (FONR)

$15.45

+0.38

(+2.52%)

Market is closed - opens 7 PM, 05 Jun 2024

Performance

  • $15.05
    $15.91
    $15.45
    downward going graph

    2.59%

    Downside

    Day's Volatility :5.41%

    Upside

    2.9%

    downward going graph
  • $12.13
    $24.05
    $15.45
    downward going graph

    21.49%

    Downside

    52 Weeks Volatility :49.56%

    Upside

    35.76%

    downward going graph

Returns

PeriodFonar Corp
3 Months
-34.85%
6 Months
-22.2%
1 Year
-12.84%
3 Years
-18.72%

Highlights

Market Capitalization
97.3M
Book Value
$25.68
Earnings Per Share (EPS)
1.57
PE Ratio
9.6
PEG Ratio
0.0
Profit Margin
10.68%
Operating Margin TTM
14.57%
Return On Assets TTM
5.41%
Return On Equity TTM
9.52%
Revenue TTM
102.7M
Revenue Per Share TTM
15.91
Quarterly Revenue Growth YOY
1.2%
Gross Profit TTM
45.7M
EBITDA
22.4M
Diluted Eps TTM
1.57
Quarterly Earnings Growth YOY
-0.49
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
81.5M
↑ 4.46%
Net Income
21.2M
↑ 8.21%
Net Profit Margin
26.04%
↑ 0.9%
FY19Y/Y Change
Revenue
87.2M
↑ 6.96%
Net Income
20.5M
↓ 3.38%
Net Profit Margin
23.53%
↓ 2.51%
FY20Y/Y Change
Revenue
85.7M
↓ 1.72%
Net Income
11.7M
↓ 42.94%
Net Profit Margin
13.66%
↓ 9.87%
FY21Y/Y Change
Revenue
89.9M
↑ 4.95%
Net Income
13.7M
↑ 16.82%
Net Profit Margin
15.2%
↑ 1.54%
FY22Y/Y Change
Revenue
97.6M
↑ 8.52%
Net Income
17.2M
↑ 26.04%
Net Profit Margin
17.66%
↑ 2.46%
FY23Y/Y Change
Revenue
98.6M
↑ 1.08%
Net Income
9.4M
↓ 45.6%
Net Profit Margin
9.5%
↓ 8.16%
Q4 FY22Q/Q Change
Revenue
24.3M
↑ 4.59%
Net Income
2.2M
↑ 16.07%
Net Profit Margin
9.2%
↑ 0.91%
Q1 FY23Q/Q Change
Revenue
25.4M
↑ 4.81%
Net Income
3.9M
↑ 72.94%
Net Profit Margin
15.18%
↑ 5.98%
Q2 FY23Q/Q Change
Revenue
25.8M
↑ 1.39%
Net Income
1.2M
↓ 67.96%
Net Profit Margin
4.8%
↓ 10.38%
Q3 FY23Q/Q Change
Revenue
2.0M
↓ 92.15%
Net Income
8.7M
↑ 603.44%
Net Profit Margin
430.05%
↑ 425.25%
Q4 FY23Q/Q Change
Revenue
25.4M
↑ 1154.87%
Net Income
3.8M
↓ 56.79%
Net Profit Margin
14.81%
↓ 415.24%
Q1 FY24Q/Q Change
Revenue
25.7M
↑ 1.31%
Net Income
1.9M
↓ 50.2%
Net Profit Margin
7.28%
↓ 7.53%
FY18Y/Y Change
Total Assets
118.3M
↑ 19.79%
Total Liabilities
16.1M
↑ 1.41%
FY19Y/Y Change
Total Assets
133.6M
↑ 12.89%
Total Liabilities
15.4M
↓ 3.91%
FY20Y/Y Change
Total Assets
180.3M
↑ 34.96%
Total Liabilities
54.0M
↑ 249.67%
FY21Y/Y Change
Total Assets
189.5M
↑ 5.13%
Total Liabilities
54.1M
↑ 0.22%
FY22Y/Y Change
Total Assets
199.3M
↑ 5.19%
Total Liabilities
53.1M
↓ 1.9%
FY23Y/Y Change
Total Assets
200.6M
↑ 0.62%
Total Liabilities
49.8M
↓ 6.31%
Q4 FY22Q/Q Change
Total Assets
197.5M
↓ 0.26%
Total Liabilities
49.4M
↓ 2.88%
Q1 FY23Q/Q Change
Total Assets
199.3M
↑ 0.93%
Total Liabilities
48.7M
↓ 1.43%
Q2 FY23Q/Q Change
Total Assets
200.6M
↑ 0.63%
Total Liabilities
49.8M
↑ 2.13%
Q3 FY23Q/Q Change
Total Assets
201.6M
↑ 0.49%
Total Liabilities
47.5M
↓ 4.57%
Q4 FY23Q/Q Change
Total Assets
202.3M
↑ 0.35%
Total Liabilities
46.0M
↓ 3.2%
Q1 FY24Q/Q Change
Total Assets
209.6M
↑ 3.64%
Total Liabilities
52.6M
↑ 14.44%
FY18Y/Y Change
Operating Cash Flow
18.7M
↑ 11.5%
Investing Cash Flow
-2.9M
↓ 31.81%
Financing Cash Flow
-6.3M
↓ 42.08%
FY19Y/Y Change
Operating Cash Flow
19.4M
↑ 3.78%
Investing Cash Flow
-18.6M
↑ 530.84%
Financing Cash Flow
-6.6M
↑ 5.1%
FY20Y/Y Change
Operating Cash Flow
20.4M
↑ 4.91%
Investing Cash Flow
7.4M
↓ 139.95%
Financing Cash Flow
-4.9M
↓ 25.93%
FY21Y/Y Change
Operating Cash Flow
19.1M
↓ 6.44%
Investing Cash Flow
-4.8M
↓ 164.93%
Financing Cash Flow
-6.6M
↑ 34.77%
FY22Y/Y Change
Operating Cash Flow
15.3M
↓ 19.84%
Investing Cash Flow
-5.2M
↑ 7.46%
Financing Cash Flow
-5.9M
↓ 11.36%
FY23Y/Y Change
Operating Cash Flow
14.5M
↓ 5.45%
Investing Cash Flow
-4.3M
↓ 16.24%
Financing Cash Flow
-7.6M
↑ 29.23%
Q4 FY22Q/Q Change
Operating Cash Flow
3.2M
↑ 17.35%
Investing Cash Flow
-473.0K
↓ 50.88%
Financing Cash Flow
-1.9M
↑ 6.93%
Q1 FY23Q/Q Change
Operating Cash Flow
4.3M
↑ 35.45%
Investing Cash Flow
-2.2M
↑ 365.96%
Financing Cash Flow
-1.9M
↑ 3.45%
Q2 FY23Q/Q Change
Operating Cash Flow
4.3M
↑ 0.73%
Investing Cash Flow
-698.1K
↓ 68.32%
Financing Cash Flow
-2.0M
↑ 1.66%

Technicals Summary

Sell

Neutral

Buy

Fonar Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fonar Corp
Fonar Corp
-14.42%
-22.2%
-12.84%
-18.72%
-23.58%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
3.26%
-4.68%
5.84%
-11.81%
94.73%
Agilent Technologies Inc.
Agilent Technologies Inc.
-6.55%
1.96%
11.03%
-4.71%
93.38%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
-0.69%
14.99%
9.83%
26.92%
112.55%
Danaher Corp.
Danaher Corp.
5.65%
19.11%
12.12%
8.8%
94.77%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
-4.66%
0.09%
6.11%
-7.43%
59.67%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fonar Corp
Fonar Corp
9.6
9.6
0.0
0.0
0.1
0.05
NA
25.68
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
48.52
48.52
4.75
11.05
0.72
0.23
NA
18.93
Agilent Technologies Inc.
Agilent Technologies Inc.
30.83
30.83
2.7
5.27
0.21
0.08
0.01
21.31
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
36.5
36.5
2.81
21.71
0.14
0.05
0.0
119.24
Danaher Corp.
Danaher Corp.
47.21
47.21
3.13
7.61
0.08
0.04
0.0
72.16
Iqvia Holdings Inc.
Iqvia Holdings Inc.
29.57
29.57
1.33
11.08
0.22
0.05
NA
34.82
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fonar Corp
Fonar Corp
NA
$97.3M
-23.58%
9.6
10.68%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$41.3B
94.73%
48.52
23.26%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$38.0B
93.38%
30.83
18.84%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$216.8B
112.55%
36.5
14.2%
Danaher Corp.
Danaher Corp.
Buy
$190.2B
94.77%
47.21
18.55%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$39.4B
59.67%
29.57
9.01%

Institutional Holdings

  • Kayne Anderson Rudnick Investment Management LLC

    9.33%
  • Dimensional Fund Advisors, Inc.

    6.13%
  • Vanguard Group Inc

    6.05%
  • MONEY CONCEPTS CAPITAL CORP

    5.29%
  • Renaissance Technologies Corp

    4.70%
  • LSV Asset Management

    1.77%

Company Information

manufacturer of state-of-the-art mri equipment located in melvillle new york.

Organization
Fonar Corp
Employees
561
CEO
Mr. Timothy R. Damadian M.D.
Industry
Health Technology

FAQs